This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

In the whole of safety profile, long-term use of deanxit might develop tardive dyskinesia and tardive akathisia, which should be highlighted to be aware of withdrawing deanxit gradually without ...

NRx Pharmaceuticals (NASDAQ: NRXP) announced it will release its first quarter 2025 financial results after market close on Thursday, May 15, 2025. The company will host a conference call at 4:30 p.m.